For our visitors who seek the latest industry news and updates to keep abreast with the goings-on
of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and
diverse feed of news items.
* H1 revenue 1,200 euros ($1,328.16) versus 0.0 euros year ago
* H1 loss for period 13.6 million euros versus loss 2.4 million euros year ago
* Financial position is expected to be positive at end of period
* Says intends to submit clinical trial applications to regulatory authorities by…
Sun Pharmaceutical Industries gains 1.5 pct
BofA-ML upgrades the stock to "buy" from "neutral"
Raises target to 1,070 rupees from 960 rupees earlier
Cites integration with Ranbaxy, price hikes at unit Taro and improvement in US supplies as key reason for the upgrade
Sequential improvement in ex-Taro US business, including…
Concordia Pharmaceuticals Inc and Par Pharmaceutical Inc have settled charges they unlawfully agreed not to compete in the sale of a generic version of Kapvay, a drug used to treat attention deficit hyperactivity disorder, the U.S. Federal Trade Commission said on Tuesday.
The FTC had alleged Concordia, a unit of…
M Pharmaceutical, Inc., a clinical-stage company developing innovative technologies for the monitoring and treatment of obesity, diabetes, and other gastroenterological disorders, announced today that it has entered into a manufacturing supply agreement with Rishena Co., Ltd., of Changzhou, China, to manufacture the Company’s Trimtec gastric functional neurostimulation device. Under the…
Harbin Gloria Pharmaceuticals Co Ltd Says plans to invest up to 176 million yuan ($27.53 million) for 70 percent stake in hospital.
Says plans to invest 100 million yuan to set up investment unit in Shenzhen.
Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd Says plans to raise up to 781.7 million yuan in private placement of shares to fund projects, replenish working capital.
Says shares have resumed trading on Aug. 17.
India has decided against giving the compulsory licence for Anglo-Swedish drugmaker AstraZeneca's key antidiabetes compound Saxagliptin sought by Hyderabad-based Lee Pharma. The Controller of Patents office rejected the application on the grounds that substitutes to the drug are readily available in the market and Lee Pharma's claim that requirements of…
Xellia Pharmaceuticals, a specialty pharmaceutical company focusing on providing important anti-infective treatments, announces the expansion of its Raleigh, NC site to enable the relocation of its North American headquarters from Grayslake, Illinois.
One year on from its acquisition of the Raleigh plant from Fresenius Kabi, Xellia has taken on new…
Horizon Pharma Plc is talking to Depomed Inc. shareholders about a revised takeover offer that would include as much as 25 percent in cash, though the total value of the proposal would be lower than its current all-stock bid.
Horizon said Thursday it could offer $32.50 a share in stock…